# DAS181 Single Dose Escalation Study in Healthy Adults

> **NCT00876161** · PHASE1 · COMPLETED · sponsor: **Ansun Biopharma, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DAS181
- **DRUG:** Lactose

## Key facts

- **NCT ID:** NCT00876161
- **Lead sponsor:** Ansun Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-18
- **Primary completion:** 2009-12
- **Final completion:** 2010-05-23
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876161, "DAS181 Single Dose Escalation Study in Healthy Adults". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00876161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*